Author:
Ye Ling,Chen Jie-hui,Zhu Sheng-lang,Xu Dan-dan,Yang Yun,Shi Ming-pei
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference49 articles.
1. Maezawa, Y., Takemoto, M., & Yokote, K. (2015). Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes. Journal of diabetes investigation, 6, 3–15.
2. Suneja, M. (2021). Diabetic Nephropathy and Diabetic Kidney Disease. Journal of Diabetes Mellitus, 11, 359–377.
3. Jiang, L., Liu, X., Hu, X., Gao, L., Zeng, H., Wang, X., Huang, Y., Zhu, W., Wang, J., Wen, J., Meng, X., & Wu, Y. (2022). METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular therapy : The journal of the American Society of Gene Therapy, 30, 1721–1740.
4. Ram, C., Jha, A. K., Ghosh, A., Gairola, S., Syed, A. M., Murty, U. S., Naidu, V. G. M., & Sahu, B. D. (2020). Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches. European Journal of Pharmacology, 885, 173503.
5. Klessens, C. Q. F., Zandbergen, M., Wolterbeek, R., Bruijn, J. A., Rabelink, T. J., Bajema, I. M., & DHT, I. J. (2017). Macrophages in diabetic nephropathy in patients with type 2 diabetes. Nephrology, Dialysis, Transplantation, 32, 1322–1329.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献